Fisher Michal

Director · CNS Pharmaceuticals, Inc.

Every open-market stock purchase Fisher Michal has reported to the SEC on Form 4 that met our signal bar, parsed straight from the filings. This page tracks where how the prices paid compare to where the stock trades now.

Total bought
$10.0K
Open-market buys
1
Companies
1
Last buy
May 18, 2026

Where the buys stand today

All reported buys

DateTickerSharesPriceValueFiling
May 18, 20262,000$5.00$10.0KSEC ↗

Follow new qualifying clusters involving Fisher Michal or other insiders

Explore qualifying clusters from public SEC filings. Pro adds email and Telegram notifications after detection.

About this data

Figures are parsed from Fisher Michal's Form 4 filings on SEC EDGAR (CIK 2139619) and cover open-market purchases (transaction code P) — grants, option exercises, and sales are excluded, which is why totals here can differ from raw filing counts. Every row links to its source document.

This page is informational and reflects public filing data. It is not investment advice.